je.st
news
Arena- Belviq Scripts Continue Troubled Path
2016-03-02 00:47:30| Biotech - Topix.net
Arena investors that have been following my coverage of Belviq sales should not be surprised by what this week's numbers delivered. Some Arena investors got a big surprise yesterday when it was revealed in a quarterly conferece call that Arena's marketing partner Eisai is essentially running a bare bones effort until after the data from a CVOT trial is released in 2018.
Tags: continue
path
scripts
arena
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||